Auranofin-13C6 is a labelled analogue of Auranofin, a new oral gold-based antiarthritis drug. Auranofin inhibits various leukocyte activation pathways at multiple sites. Auranofin inhibits the release of inflammatory mediators from human macrophages, basophils, and pulmonary mast cells. Auranofin is an efficient inducer of mitochondrial membrane permeability transition pore in the presence of calcium ions related to its inhibition of mitochondrial thioredoxin reductase. CAS No: Unlabelled: 34031-32-8 Molecular Formula: C14C6H34AuO9PS Molecular Weight: 684.44 Storage and Stability: Store at -20C. For maximum recovery of product, centrifuge the original vial prior to removing the cap.
Molecular Weight:
684.44
* VAT and and shipping costs not included. Errors and price changes excepted
